Infirst Healthcare to promote pediatric cough-cold brand Dr. Cocoa in U.S. market

LONDON — Infirst Healthcare earlier this month secured the rights to market Dr. Cocoa, an award-winning cocoa-flavored pediatric cough remedy.

“Many cough treatments have deficiencies in their efficacy, safety and compliance profiles and Infirst Healthcare is committed to finding solutions that address these issues," Manfred Scheske, Infirst CEO said. "Introducing compliance optimized pediatric products that taste better to children is a step in this direction. We are excited about the start of our U.S. operations in the pediatric OTC market.

Dr. Cocoa was named "Best Product" at the 2013 US Cough & Cold ECRM conference, an award sponsored by DSN. The patent protected line of products has been formulated with real chocolate in order to improve compliance for better symptom relief. 

The Dr. Cocoa brand is brought to life through the Dr. Cocoa Owl character which depicts the family doctor speaking to children and parents in a knowledgeable and credible way, and will be used throughout all marketing and communications activity, the company noted. 

With this agreement, Infirst Healthcare now holds the exclusive global rights for the use of cocoa and chocolate in cough products. Infirst Healthcare will be building its U.S. presence and preparing for the launch of Dr. Cocoa in 2014. Infirst Healthcare will be represented in the U.S. by Advantage Consumer Healthcare.